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Abstract
 
Mice deficient for the B cell–restricted transcription factor Pax5 show a defect in the V
 
H
 
 to
DJ
 
H
 
 rearrangement step of immunoglobulin heavy chain gene assembly even though the ex-
pression of the V(D)J recombinase is not diminished in 
 
Pax5
 
 
 
/
 
 
 
 pro–B cells. To investigate
whether Pax5 is limiting for V
 
H
 
 to DJ
 
H
 
 rearrangement, we generated transgenic mice which
express Pax5 in developing thymocytes. We show that enforced expression of Pax5 in thy-
mocytes results in a partial block in T cell development due to defective pre-TCR signaling in
 
 
 
-selection. Moreover, our results demonstrate that expression of Pax5 in early thymocytes is
sufficient to induce V
 
H
 
 to DJ
 
H
 
 rearrangements in CD4
 
 
 
CD8
 
 
 
 T cells and lead us to suggest
that Pax5 may play a direct role in the lineage-specific regulation of immunoglobulin heavy
chain gene rearrangement.
Key words: lymphocyte development • V(D)J recombination • gene expression regulation • 
transgenesis • immunoglobulin
 
Introduction
 
V(D)J recombination is regulated in several ways (1). First,
it is lineage specific, with Ig genes completely rearranging
only in B cells and TCR genes completely rearranging
only in T cells. Second, there is a preferred order to the
rearrangement process with Ig heavy chain (IgHC) locus
preceding Ig light chain (IgLC) locus rearrangement in B
cells and TCR
 
 
 
 locus preceding TCR
 
 
 
 locus rearrangement
in T cells. Also, in both the IgHC and TCR
 
 
 
 loci D to J
rearrangement precedes V to DJ rearrangement and direct
V to D rearrangement occurs rarely if at all. Finally, the
gene rearrangement process at most loci is subject to allelic
exclusion. That is, an individual B or T cell makes only
one productive (in frame) rearrangement at each locus, result-
ing in its ability to produce only a single Ig or TCR molecule.
Regulated changes in chromatin structure underlie most
if not all aspects of substrate choice by the V(D)J recombinase
(2). This idea, known as the “accessibility hypothesis,”
arose from initial observations which correlated the tran-
scription of unrearranged gene segments with their activation
for rearrangement. It was shown subsequently that mutations
which eliminate promoters or enhancers associated with
rearranging loci greatly diminish rearrangement of the altered
locus (1). Additional work has implicated specific transcription
factors in the regulation of recombinase accessibility. For
example, overexpression of either E47 or EBF can activate
chromosomal Ig gene rearrangement in nonlymphoid cells
transfected with 
 
RAG1
 
 and 
 
RAG2
 
 (3). Furthermore, mice
with a null mutation in the 
 
Pax5
 
 gene, which encodes the
B cell–restricted transcription factor Pax5 (BSAP), show a
profound block in B cell development at the pro–B cell
stage (4). Most 
 
Pax5
 
-null pro–B cells contain DJ
 
H
 
 but not
VDJ
 
H
 
 rearrangements at their IgHC loci, leading to the
suggestion that Pax5 is necessary to fully activate the V
 
H
 
 to
DJ
 
H
 
 step in IgHC gene assembly.
 
Two other aspects of the regulation of IgHC gene re-
arrangement focus particular interest on the V to DJ step.
First, this is the step which is subject to allelic exclusion.
Nearly all developing B cells undergo D to J rearrangement
on both HC alleles, but only one of these alleles undergoes
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productive V to DJ rearrangement. Furthermore, IgHC
transgenic mice show normal D to J rearrangement but
greatly diminished V to DJ rearrangement at their endoge-
nous IgHC loci (1). Finally, this is the step which shows
strict lineage specificity. IgHC D to J rearrangement occurs
frequently in developing T cells (5), but V to DJ rearrange-
ment is limited to developing B cells.
Given the fact that the state of IgHC rearrangement in
 
Pax5
 
-null pro–B cells is similar to that in normal develop-
ing T cells and that developing T cells do not express Pax5,
we hypothesized that T cells perform D
 
H
 
 to J
 
H
 
 but not V
 
H
 
to DJ
 
H
 
 rearrangement because Pax5 is absolutely required
for the latter step in IgHC gene assembly. To test this idea,
we have generated and analyzed Pax5 transgenic mice
which express this B lineage transcription factor in devel-
oping thymocytes.
 
Materials and Methods
 
Antibodies and Flow Cytometry.
 
The following antibodies
were purchased from either BD Biosciences or CALTAG Labo-
ratories: FITC–anti-CD3
 
 
 
 (145–2C11), -CD4 (RM4–5), -CD8
 
 
 
(53–6.7), -Thy1.2 (CD90.2) (53–2.1); PE–anti-CD25 (PC61),
-CD4 (RM4–5), -CD19 (1D3); CyChrome–anti-CD44 (IM7);
and bi–anti-CD4 (RM4–5), -CD8
 
 
 
 (CT-Cd8
 
 
 
). For analysis,
live cells were gated based on forward and side scatter, and over
100,000 events were collected. CD4/CD8 double negative T cell
(DN) and CD4/CD8 double positive T cell (DP) thymocytes
were purified with an AutoMACS magnetic cell sorter (Miltenyi)
as described (6) or using a MoFlo cell sorter (Cytometrix). Rou-
tinely, purity of all cell preparations was 
 
 
 
95% unless otherwise
specified in the text.
 
Rearrangement PCR and Ligation-mediated–PCR.
 
100 ng of
genomic DNA from DP or pre–B (CD43
 
 
 
B220
 
 
 
IgM
 
 
 
) cells was
used to assay for IgHC gene rearrangements. PCR assays for D
 
H
 
to J
 
H
 
 and V
 
H
 
 to DJ
 
H
 
 rearrangements were performed as described
(7). The locus-specific PCR primers and probes used for ligation-
mediated (LM)–PCR were described previously (8, 9).
 
PCR Fragment Length Polymorphism.
 
Total thymocytes were
first depleted of DP and SP populations by incubation of cell sus-
pensions with biotinylated antibodies specific for CD4, CD8, and
CD3
 
 
 
 followed by negative selection using streptavidin-conju-
gated microbeads (Miltenyi). DN cells were further stained with
PE-conjugated anti-CD25 and CyChrome-conjugated anti-
CD44 antibodies. CD44
 
 
 
CD25
 
 
 
 DN3 cells were purified using
a MoFlo cell sorter (Cytometrix). PCR amplification of the
TCR
 
 
 
 CDR3 region using specific V and J primers was per-
formed essentially as described (10).
 
Online Supplemental Material.
 
Fig. S1 shows Western blot and
RT-PCR analyses of transgene expression. Fig. S2 displays CD19
expression in Pax5 transgenic thymus. Fig. S3 shows RT-PCR
analysis of gene expression in Pax5 transgenic thymus. Fig. S4
shows CDR3-length analysis of VDJ
 
 
 
 rearrangements in Pax5
transgenic and control thymocytes. Fig. S5 shows VDJ
 
H
 
 rearrange-
ment in Pax5 transgenic thymocytes from 
 
Ig
 
 
 
 
 
/
 
 
 
 mice. In addi-
tion, Supplemental Materials and Methods are provided regarding
the generation of the transgenic construct, the performance of
RT-PCR, and the analysis of transgene expression by Western blot.
Figs. S1–S5 and Supplemental Materials and Methods are available
at http://www.jem.org/cgi/content/full/jem.20032249/DC1.
 
Results and Discussion
 
Impaired T Cell Development in CD2EP-Pax5 Transgenic
Mice.
 
A murine 
 
Pax5
 
 cDNA, cloned in between the hu-
man CD2 promoter and its locus control region, was used
to generate transgenic mice by pronuclear injection (11).
Analysis by Western blot of whole cell thymic extracts
from multiple founder lines showed that in two founders
the expression level of Pax5 appeared comparable to that in
the BM (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20032249/DC1).
In three independent lines of CD2EP-
 
Pax5
 
 transgenic
mice, we observed an approximately threefold decrease in
thymocyte numbers compared with those of control litter-
mates (Fig. 1 B, data shown from only two founders). Anal-
ysis of CD4/CD8 expression revealed a fivefold increase in
Figure 1. Impaired T cell development in CD2EP-Pax5 transgenic
mice. (A) FACS® analysis of CD4 and CD8 expression on thymocytes
from 4-wk-old littermate control or transgenic mice (top). Electronically
gated CD3 CD4 CD8  DN thymocytes from 2-wk-old control or
transgenic mice were stained with anti-CD25 and anti-CD44 antibodies
(bottom). Percentages represent the means and SDs of live-gated subpop-
ulations from six mice of each genotype. (B) Absolute cell numbers were
calculated for total thymocytes and the thymocyte subsets described in A
(top). The error bars represent mean   SD values for control and trans-
genic mice (n   12). 
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the percentage of DN thymocytes and a slight decrease in
the percentage of DP thymocytes in the transgenic mice
compared with littermate controls (Fig. 1 A, top). Interest-
ingly, the absolute number of DN thymocytes in transgenic
mice remained similar to that in control littermates, whereas
the number of DP thymocytes was considerably decreased
(Fig. 1 B). We went on to examine DN thymocyte popula-
tions for CD44 and CD25 expression and observed a small
increase in the proportion of CD44
 
 
 
CD25
 
 
 
 (DN3) cells
and a decrease in the proportion of CD44
 
 
 
CD25
 
 
 
 (DN1)
cells in the transgenic mice (Fig. 1 A). The decrease in DN1
cells may be due to expression of Pax5 in a fraction of early
thymic progenitors leading to their inefficient entry into the
pool of developing thymocytes (12). Collectively, these ob-
servations indicate that ectopic expression of Pax5 in early
thymocytes leads to a partial developmental block at the
DN to DP transition.
 
Appearance of Rare CD19
 
 
 
 Cells in the Thymi of CD2EP-
Pax5 Transgenic Mice.
 
Given that ectopic Pax5 expression
inhibits T cell development and B cell commitment depends
on Pax5 (12), we asked whether overexpression of Pax5 in
early thymocyte precursors promotes intrathymic B cell de-
velopment. We found a small fraction (
 
 
 
1–3%) of CD19
 
 
 
cells in the thymus of transgenic mice but not in control
littermates (Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20032249/DC1). The majority of the
CD19
 
 
 
 cells from founder #10 coexpress CD4 and CD8
or Thy1.2 (not depicted), whereas CD19 is not coex-
pressed with CD4 and CD8 on cells from founder #2. The
level of CD19 expression on thymocytes from founder #10
is clearly greater than that expressed on littermate controls
but far less than that expressed on wild-type splenic B cells
(Fig. S2 C).
To test whether these T cells also express other B lineage
markers, we purified DP thymocytes by flow cytometry
from either transgenic or control mice and used RT-PCR
to assay for expression of early B cell–related molecules.
We found that 
 
Pax5
 
 transgenic DP T cells express the di-
rect Pax5 targets CD19 and BLNK (13) but do not express
other early B cell–specific transcripts such as 
 
 
 
5, VpreB,
and Ig
 
 
 
 (Fig. S3, available at http://www.jem.org/cgi/
content/full/jem.20032249/DC1). We conclude from
these studies that Pax5 expression in thymocytes activates
direct Pax5 targets but does not activate the full genetic
program of early B cell development.
These and more detailed analyses failed to reveal a quan-
titative increase in B cell development in the BM or the in-
duction of significant amounts of B cell development in the
thymus (not depicted). These findings are in contrast to
those from a recently reported study of knock-in mice in
which 
 
Pax5
 
 was placed under the control of the 
 
Ikaros
 
 lo-
cus (12). In these mice, Pax5 expression in hematopoietic
stem cells resulted in an extreme skewing of lymphopoiesis
toward the B cell lineage. T cell development was blocked,
presumably due to the repression of Notch1 transcription
(12). The discrepancy between our results and those of
Souabini et al. could be due to a difference in the onset of
ectopic Pax5 expression. It was shown previously that ex-
pression of a similar hCD2 promoter/locus control region–
driven transgene is first detected at the DN1 stage of T cell
development in a heterogeneous fashion but that transgene
expression does not become uniform in all thymocytes un-
til the DN3 to DN4 transition (11). Thus, it seems likely
that commitment to the T cell lineage takes place before
the expression of our CD2 promoter–driven Pax5 trans-
gene. In distinction to the previous study, the relatively
later onset of Pax5 expression in our transgenic system al-
lows one to assess the effects of Pax5 expression after the
onset of early T cell development.
 
Ectopic Pax5 Expression in the Thymus Inhibits 
 
 
 
-Selection.
 
Transition from the DN to DP stage, often referred to as
 
 
 
-selection, is accompanied by various phenotypic changes,
including cell cycle entry and selection for in-frame TCR
 
 
 
rearrangement (14). To test whether the increased percent-
age of DN cells in the thymi of transgenic mice was a con-
sequence of faulty 
 
 
 
-selection, we first analyzed DN3
(CD25
 
 
 
CD44
 
 
 
) cells for forward scatter as an indirect
marker of cell cycle activation. Strikingly, we found a sig-
nificant reduction in the percentage of large, presumably
cycling cells within the DN3 population of 
 
Pax5
 
 transgenic
mice (Fig. 2 A). To test whether this defect was due to defi-
cient TCR
 
 
 
 locus rearrangement, we measured recombina-
tion reaction intermediates (broken signal ends) in sorted
DN3 and DN4 cells from control and transgenic mice (Fig.
Figure 2. Pax5 expression in
the thymus affects  -selection
but not TCR  gene segment re-
arrangement. (A) Gated DN3
(CD44 CD25 ) cells were ana-
lyzed for forward scatter. The
results are displayed as overlap-
ping histograms of control (WT,
unshaded) and transgenic (Tg,
shaded) thymocytes. The percent-
age of large cycling cells is indi-
cated, including the mean and
SD (n    3). (B) Linker-ligated
DNAs from control and trans-
genic DN3 and DN4 T cells
were subjected to LM-PCR
with primers specific for the de-
tection of double stranded breaks
at the RSSs 3  or 5  of D 1 as
indicated. CD14 is a nonrearrang-
ing locus control PCR. (C) PCR
fragment length polymorphism
analysis of the CDR3 region of
fully rearranged TCR  alleles
using template DNA purified
from sorted DN3 cells from
control (Ctrl) or transgenic (Tg)
mice (some assays used two inde-
pendent  samples of founder #2
DNA). Results of analyses focus-
ing on V 5.2 or 8.2 to J 1.2
rearrangements are shown. Sim-
ilar results were obtained using a
downstream primer specific for
J 2.1 (not depicted). 
Pax5 Activates V to DJ Rearrangement
 
828
Figure 3. Ectopic Pax5 expression induces VH to DJH
rearrangement in transgenic DP thymocytes. Threefold
serially diluted genomic DNAs from FACS®-sorted
control DP thymocytes (lanes 1–4), transgenic DP thy-
mocytes  (lanes 5–8), or wild-type BMpre–B cells
(B220 CD43 IgM ) (lanes 9–13) were subjected to PCR
analysis for DH to JH (A) and VH to DJH (B–E) gene rear-
rangements. An equimolar mixture of degenerate VHJ558,
VH7183, and VHQ52 family-specific primers (VH mix)
paired with a unique primer hybridizing 3  of JH3 was used
in B, whereas each degenerate VH primer was used in
isolation in C–E as indicated. Genomic DNA samples
purified from sorted DN (F) and DP (G) thymocytes from
two independent samples of control and Pax5 transgenic
mice were analyzed by LM-PCR to detect broken signal
end recombination reaction intermediates associated with
DH to JH rearrangement (3 DH, top), VH to DJH rearrange-
ment (5 DH, middle), and V  to J  rearrangement (5 J ,
bottom). Amplification of a nonrearranging control locus
(CD14) was used as a DNA recovery control. H2O denotes
reactions lacking DNA template and   ctrl denotes control
assays which contained BM DNA.
2 B). We found that dsDNA breaks at both the 3  and 5  of
D 1 RSSs, which are associated with D  to J  and V  to
DJ  rearrangements, respectively, appear slightly increased
in DN3 cells from transgenic mice compared with litter-
mate controls. Thus, the lower percentage of large cycling
cells in transgenic thymocytes cannot be explained by defi-
cient assembly of genes encoding the TCR  chain.
To determine whether the defect in  -selection might
be due to a generalized disruption of the transcriptional
program in progenitor T cells associated with the expres-
sion of this B lineage transcription factor, we used real-time
RT-PCR to compare the levels of preT ,  Notch1, and
LEF-1 mRNA in DN thymocytes from transgenic and
control mice (Fig. S3 C). No significant differences were
observed, indicating that ectopic Pax5 expression does not
affect expression of these critical genes.
Signals derived from the pre-TCR complex result in
clonal expansion of thymocytes with functionally rear-
ranged TCR  chains (14). To determine whether ectopic
Pax5 expression disrupts this aspect of  -selection, we used
a PCR fragment–length polymorphism assay to assess both
TCR  CDR3 length heterogeneity and the distribution of
in-frame rearrangements in sorted DN3 cells from control
and transgenic mice. The imprecise nature of V(D)J joining
results in a continuous distribution of CDR3 amplicon
fragment lengths. Rapid cell division among cells with a
productive TCR  rearrangement results in the enrichment
of PCR fragments whose lengths correspond to potential
open reading frames within TCR . Using primers that
amplify across the V(D)J junction within TCR  alleles,
PCR products generated using genomic DNA from con-
trol DN3 cells showed a length distribution with a period-
icity of three nucleotides, which is indicative of enrichment
for productive TCR  rearrangements (Fig. 2 C and Fig.
S4, available at http://www.jem.org/cgi/content/full/
jem.20032249/DC1). In contrast, CDR3 length distribu-Hsu et al.  829
tion in DN3 cells from transgenic mice was relatively ran-
dom, suggesting a defect in  -selection. We hypothesize
that defects in pre-TCR signaling in Pax5 transgenic mice
may result from up-regulation of BLNK and CD19 expres-
sion in early thymocytes. These components of the B cell
signaling machinery may interfere with the function of the
T cell–specific adaptors SLP-76 or LAT. Additional work
will be required to test this hypothesis.
Pax5 Expression Is Sufficient to Induce VH to DJH Recombi-
nation at the IgHC Locus. To test whether Pax5 plays an
important role in controlling the B cell–specific VH to DJH
rearrangement step of IgHC gene assembly, we examined
the rearrangement status of the IgHC locus in sorted DP
thymocytes from transgenic and control mice using a direct
PCR assay (7). The purity of these sorted cells was  98%.
Consistent with earlier work (5), frequent DH to JH rear-
rangements were readily detectable in both BM pre–B cells
and DP thymocytes from either transgenic or control mice
(Fig. 3 A). Interestingly, although the DP thymocytes from
control mice lacked VH to DJH rearrangements, these rear-
rangements were readily detectable in DP thymocytes from
transgenic mice (Fig. 3 B). By comparing PCR signals be-
tween transgenic DP thymocytes and sorted BM pre–B
cells from wild-type mice, we estimate the frequency of VH
to DJH rearrangements in DP Pax5 transgenic thymocytes
to be  5–10% that of BM pre–B cells (Fig. 3 B).
This observation was further supported by examination of
V(D)J recombination reaction intermediates using a previ-
ously described LM-PCR approach. Double strand DNA
breaks at RSSs 5  of DH, which represent intermediates in the
VH to DJH rearrangement step, were detected in DNA puri-
fied from the DP thymocytes of transgenic but not control
mice, whereas DNA breaks associated with TCR  locus rear-
rangement were detected in all samples (Fig. 3 G). Interest-
ingly, we failed to detect 5  of DH broken ends in DN thy-
mocytes from either control or transgenic mice (Fig. 3 F),
leading us to conclude that Pax5-induced VH to DJH rear-
rangements occur mainly during the DP stage of T cell devel-
opment. In contrast, 3  of DH breaks were detected in DN
and DP cells from both transgenic and control mice (Fig. 3, F
and G). The level of these breaks was greater in DP samples
from the transgenic samples, corresponding to greater levels of
DJH joints observed by direct PCR (Fig. 3 A). We obtained
similar results when we crossed the CD2EP-Pax5 transgene
onto a Ig  /  genetic background where B cell development
is blocked at an early stage (15) (Fig. S5, available at http://
www.jem.org/cgi/content/full/jem.20032249/DC1). This
led us to conclude that contaminating B cells could not ac-
count for the VH to DJH rearrangements observed in trans-
genic thymocytes. In summary, our results indicate that ex-
pression of Pax5 alone in early thymocytes is sufficient to
induce VH to DJH rearrangement in T lineage cells.
It was reported recently that pro–B cells from Pax5-defi-
cient mice show a far more significant defect in rearrange-
ment of the DH-distal VHJ558 gene family relative to that
of the more DH-proximal VH gene families (16). Therefore,
we used PCR assays to separately examine the use of
VHJ558, VH7183, and VHQ52 gene segments. As shown in
Fig. 3, C and D, the VH7183 and VHQ52 gene families ac-
counted for the vast majority of VH to DJH rearrangements
in DP thymocytes from transgenic mice. In striking con-
trast, rearrangements using the VHJ558 gene family were
barely detectable in transgenic thymocytes (Fig. 3 E). In
addition, we were able to detect VH7183 but not VHJ558
gene segment transcripts in transgenic DP thymocytes (not
depicted). Thus, our findings suggest that the extent of VH
to DJH rearrangement induced by ectopic Pax5 expression
in the thymus progressively decreases as the distance of a
VH gene family from the DH cluster increases. However,
the results of Hesslein et al. (16) suggest just the opposite—
that rearrangement of the distal VHJ558 gene family in
pro–B cells is far more dependent on Pax5 than rearrangement
of the more proximal VH gene families. These differences
may be due to differential expression of any of a large num-
ber of other transacting factors in B and T cell progenitors.
Given the fact that pro–B cells from Pax5 /  mice dis-
play amounts of VHJ558 germline transcription and histone
acetylation that are indistinguishable from wild-type pro–B
cells, these workers (16) concluded that Pax5 regulates the
accessibility of VHJ588 gene segments at a level distinct
from germline transcription and histone acetylation. Al-
though histone acetylation appears to correlate well with
accessibility of the V(D)J recombinase in many cases (17–
19), we were also unable to detect changes in H3 or H4
acetylation which correlated with the Pax5-dependent ac-
tivation of VH to DJH rearrangement in DP transgenic thy-
mocytes (not depicted). Surprisingly, we did find that the
distal VHJ558 family of IgHC gene segments was relatively
hyperacetylated (although not to the same level as seen in
pro–B cells) in both control and Pax5 transgenic thymus
even though they were not found to be accessible to the
recombinase in either instance (not depicted). Thus, it ap-
pears that variations in histone acetylation may not in a
simple fashion explain the selectivity of VH accessibility.
Additional work will be required to determine whether
other specific modifications more closely track with VH
gene segment accessibility.
It is possible that the preferential rearrangement of DH-
proximal VH gene segments observed in the DP transgenic
thymocytes is a result of the IL-7 dependence of distal VH
gene segment rearrangement. Several labs have shown that
the IL-7 signaling pathway is involved in promoting local
accessibility of VHJ558 genes (18, 20). Expression of the IL-
7R  chain is low at the DP stage of T cell development
(21). Perhaps VHJ558 genes are inactive at the DP stage be-
cause low levels of IL-7R  expression make these DP thy-
mocytes poorly responsive to IL-7. Therefore, it is possible
that IL-7R signaling and Pax5 cooperate in the control of
distal VH gene segment recombination. However, given
the phenotypic similarity between IL-7R  /  and Pax5 / 
mice and the observation that Pax5 transcript levels are de-
creased in IL-7R  /  BM cells (20), we cannot rule out
the possibility that Pax5 acts as a downstream target of IL-
7R signaling in developing B cells.Pax5 Activates V to DJ Rearrangement 830
This work shows that Pax5 expression is sufficient to ac-
tivate VH to DJH rearrangement in T cells and by inference
may play a similar role in B cells. Evidence for the involve-
ment of specific transcription factors in modulating the ac-
cessibility of specific gene segments to the recombination
machinery is scarce. In one study, STAT5 was shown to
bind to and promote recombinase accessibility of the
TCR  locus (22). Several studies have implicated E2A
proteins (E12 and E47) in the regulation of both Ig and
TCR gene segment recombination (3, 23, 24). These ef-
fects might depend on the known interaction between
transcription factors and chromatin remodeling complexes.
However, we have been unable to convincingly demon-
strate direct Pax5 interaction with VH gene segments using
a ChIP approach. Thus, further studies on the interactions
of various chromatin-modifying complexes with VH region
chromatin in transgenic mice should provide a better un-
derstanding of how Pax5 facilitates targeting of recombina-
tion machinery to specific VH gene segments.
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